JORIE SANFORD: Open Payments
NPI 1982655940 · COLUMBIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 19 payments from 9 companies in 2025. Trend: 2023 $181 · 2024 $287 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $90 |
| Astellas Pharma US Inc | 5 | $77 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $47 |
| ABBVIE INC. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Auvelity, Veozah, GEMTESA, JARDIANCE, VRAYLAR, TRELEGY ELLIPTA, MOUNJARO, REXULTI.
Industry payments across LA — which companies pay providers there.
